Vibrotactile Coordinated Reset in Parkinson's Disease - Proof of Concept Study
- Conditions
- Parkinson Disease
- Interventions
- Device: Stanford Glove
- Registration Number
- NCT06028477
- Lead Sponsor
- Stanford University
- Brief Summary
The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on Parkinson's symptoms. vCR will be administered with a device called the Stanford Glove. vCR is expected to provide patients with a non-invasive alternative to the most widely used treatments such as Levodopa and/or deep brain stimulation. Patients will be followed for 14 months.
- Detailed Description
The purpose of this study is to test the efficacy of vibrotactile coordinated reset stimulation on human subject participants with Parkinson's disease and inform the investigators on whether unilateral stimulation could be as effective as bilateral stimulation at producing clinically significant improvements in symptoms.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 34
Ages 18 or older
- Diagnosed with idiopathic Parkinson's Disease
- Fluent in English
- Off-state UPDRS III motor score at least 30, as assessed within the past 6 months before study consent or at Screening Visit.
- Demonstrates understanding of the study requirements and is able and willing to sign the informed consent form and complete study procedures.
- Participation in another drug, device, or biologics trial concurrently or within the preceding 30 days. Any other trial participation should be approved by the Principal Investigators.
- Pregnancy, breast-feeding or wanting to become pregnant
- Physical limitations unrelated to PD that would affect motor ratings
- Has implantation of a medical device
- Sensory abnormalities of the fingertips
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Active stimulation Stanford Glove Participants will receive active stimulation between 2 hours minimum and 4 hours maximum of daily vCR or sham stimulation (2 hours twice daily) at home for the first month (30 days), followed by a minimum of 1.5 hours and a maximum of 2.5 hours of daily vCR Sham Stimulation Stanford Glove Participants will receive sham stimulation between 2 hours minimum and 4 hours maximum of daily vCR or sham stimulation (2 hours twice daily) at home for the first month (30 days), followed by a minimum of 1.5 hours and a maximum of 2.5 hours of daily vCR
- Primary Outcome Measures
Name Time Method Change in MDS-Unified Parkinson's Disease Rating Scale Part III Scale Score Baseline and month 6 Mean change in the MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III score.
Minimum score - 0 indicates normal functioning Maximum score - 132 indicated severe impairment
Lower scores indicate greater functionality and higher scores indicate severe impairment in functionality.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Stanford University
🇺🇸Stanford, California, United States